Concepedia

George N. Karageorge

GN

Statistics

Publications

5

Citations

72

H-Index

5

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

George N. Karageorge is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and neuropharmacology.

Publications per year

2004–2018

5

Publications

5

BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder

Lawrence R. Marcin, Jayakumar Warrier, Srinivasan Thangathirupathy et al. · ACS Medicinal Chemistry Letters · 2018 · 17 citations · Full text

, , +17

Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides

James R. Epperson, Marc A. Bruce, John D. Catt et al. · Bioorganic & Medicinal Chemistry · 2004 · 16 citations

, , +2

Synthesis of novel serotonergics and other N-alkylamines using simple reductive amination using catalytic hydrogenation with Pd/C

George N. Karageorge, John E. Macor · Tetrahedron Letters · 2011 · 15 citations

, , +15

Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists

George N. Karageorge, Stephen R. Bertenshaw, Lawrence G. Iben et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 13 citations · Full text

, , +9

Synthesis of dihydropyrano[3,2-e]indoles as rotationally restricted phenolic analogs of 5-hydroxyindole—thermal Claisen approach versus gold catalysis

George N. Karageorge, John E. Macor · Tetrahedron Letters · 2010 · 11 citations

, , +8

1–5 of 5